BAM Logo

Leukaemia Diagnostic Interpretation (Part 2)

[Leukaemia Diagnostic Interpretation (Part 2)]

EPTIS factsheet 146080 | Last revision 2022-06-24 | URL: https://www.eptis.bam.de/pts146080 https://www.eptis.bam.de/pts146080

PT provider
PT provider UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping
Based in United Kingdom
Language(s) English
Product groups
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Web based Web based programme to assess a laboratory's ability to diagnose leukaemia Morphology analysis
Diagnosis interpretation
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards ISO17043:2010, ISO15189:2012, ISO13528:2015
Additional, subsidiary aims
Number of participants 625
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/IEC 17043

Operation is commissioned / requested by
Fees and frequency
Participation fee Please contact UKNEQASLI for details
Regularly operated Yes (6 per annum)
Year of first operation 1986
Contact details of the PT provider
Provider Contact person
UK NEQAS for Leucocyte Immunophenotyping
4th Floor, Pegasus House, 463a Glossop Road
S10 2QD Sheffield
United Kingdom

Phone: +44 (0) 114 2673600
Web: http://www.ukneqasli.co.uk http://www.ukneqasli.co.uk
Mr Sam Nti
Phone: +44 (0) 114 2673600
Email: admin@ukneqasli.co.uk admin@ukneqasli.co.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5